Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1942 |
Phytochemical name or plant extracts |
(E)-resveratrol 3-O-rutinoside |
PMID |
30346066 |
Literature evidence |
In addition, compounds 1-3 showed low toxicity against normal human prostate cell line, with selectivity indices greater than five across the carcinoma cells, indicating that the compounds possess potential in the development of low-toxicity chemotherapeutic agents. |
IUPAC name |
(2S,3R,4S,5S,6R)-2-{3-hydroxy-5-[(1E)-2-(4-hydroxyphenyl)ethenyl]phenoxy}-6-({[(1R,2R,3R,4S,5R)-2,3,4-trihydroxy-5-methylcyclohexyl]oxy}methyl)oxane-3,4,5-triol |
Phytochemicals’ class or type of plant extracts |
Resveratrol derivative |
Source of phytochemicals or plant Extracts |
Commiphora africana |
|
Geographical availability |
Angola, Benin, Botswana, Burkina, Cameroon, Caprivi Strip, Chad, Djibouti, Eritrea, Ethiopia, Gambia, Ghana, Ivory Coast, Kenya, KwaZulu-Natal, Malawi, Mali, Mauritania, Mozambique, Namibia, Niger, Nigeria, Northern Provinces, Rwanda, Senegal, Somalia, Sudan, Swaziland, Tanzania, Togo, Uganda, Zambia, Zaïre, Zimbabwe |
Plant parts |
Stem |
Other cancers |
NA |
Target gene or protein |
NA |
Gene or Protein evidence |
NA |
Target pathways |
NA |
IC50 |
16.80 μM against MCF7 |
Potency |
Displayed the highest antiproliferative effect on the cell lines, with IC50 values of 16.80, 21.74, 17.89, and 17.44 μM, against MCF7, A549, PC3, and HepG2 human cancer cell lines, respectively. |
Cell line/ mice model |
MCF-7, A549, PC3, and HepG2 |
Additional information |
NA |
PubChem ID |
NA |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:127576-1 |
Safety |
compounds 1-3 showed low toxicity against normal human prostate cell line, with selectivity indices greater than five across the carcinoma cells, indicating that the compounds possess potential in the development of low-toxicity chemotherapeutic agents. |